Page last updated: 2024-08-26

artesunic acid and Hemorrhagic Fever, Ebola

artesunic acid has been researched along with Hemorrhagic Fever, Ebola in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Dyall, J; Ekins, S; Foil, DH; Goodin, C; Holbrook, MR; Lane, TR; Liang, JY; Madrid, PB; Mercer, L; Postnikova, E; Zhou, H1
Ansumana, R; Bangura, H; Boie-Jalloh, M; Idris, M; Jacobsen, KH; Lamin, JM; Sahr, F; Sesay, S1

Other Studies

2 other study(ies) available for artesunic acid and Hemorrhagic Fever, Ebola

ArticleYear
Repurposing Pyramax®, quinacrine and tilorone as treatments for Ebola virus disease.
    Antiviral research, 2020, Volume: 182

    Topics: Antiviral Agents; Artesunate; Drug Combinations; Drug Repositioning; Drug Synergism; Ebolavirus; HeLa Cells; Hemorrhagic Fever, Ebola; Humans; Lysosomes; Machine Learning; MCF-7 Cells; Naphthyridines; Quinacrine; Tilorone; Virus Internalization

2020
Ebola in Freetown area, Sierra Leone--a case study of 581 patients.
    The New England journal of medicine, 2015, Feb-05, Volume: 372, Issue:6

    Topics: Adolescent; Adult; Anti-Infective Agents; Artemisinins; Artesunate; Ceftriaxone; Child; Combined Modality Therapy; Epidemics; Ethanolamines; Female; Fluid Therapy; Fluorenes; Hemorrhagic Fever, Ebola; Humans; Lumefantrine; Male; Metronidazole; Middle Aged; Sierra Leone; Vitamin K; Young Adult

2015